Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Physical activity may reduce immune cell activation to improve brain health in Alzheimer's disease

No one will disagree that an active lifestyle is good for you, but it remains unclear how physical activity improves brain health, particularly in Alzheimer's disease.

22 Nov 2021

KHN’s ‘What the Health?’: Boosting confusion

With covid caseloads rising across much of the country, several governors and mayors are unilaterally expanding access to booster shots, getting out ahead of federal health officials.

18 Nov 2021

Smartphone memory apps can help older adults with mild dementia to complete daily tasks

Results from a new study published in the Journal of the American Geriatrics Society show that older adults with mild dementia can learn to use smartphone memory aids to help them remember to complete everyday tasks that are important to their quality of life.

17 Nov 2021

Novel long-read sequencing reveals complete repertoire of brain-expressed gene isoforms

New research led by the University of Exeter has shed light on the complexity of gene expression in the brain by characterizing the extent of isoform diversity in the human and mouse cortex, including the identification of novel isoforms of genes involved in diseases including Alzheimer's disease, autism and schizophrenia.

16 Nov 2021

New AI application reads eye movements

Eye movements read by a new AI application can reveal thoughts, memories, goals — and brain diseases.

16 Nov 2021

Study offers new insight into the role of tau proteins in ALS pathogenesis

A team led by investigators at Massachusetts General Hospital has shown that people living with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, who carry a mutation in the C9orf72 gene exhibit elevated levels of tau and phosphorylated tau protein in the motor cortex region of the brain.

15 Nov 2021

Scientists develop a promising new approach to potentially treat Alzheimer's disease

A promising new approach to potentially treat Alzheimer's disease – and also vaccinate against it – has been developed by a team of UK and German scientists.

15 Nov 2021

Common hypertension drug not effective in slowing down the progression of Alzheimer's disease

New research led by the University of Bristol, has shown the drug losartan, normally used to treat high blood pressure (hypertension), is not effective in slowing down the progression of Alzheimer's disease (AD) in people with mild-to-moderate disease after 12 months of treatment.

15 Nov 2021

£375 million Government funding to improve treatment for neurodegenerative diseases

People living with neurodegenerative diseases could live longer, healthier lives due to innovative new research, following a government commitment to invest £375 million over the next 5 years.

14 Nov 2021

Will the future of global health rely upon addressing air pollution?

We speak to Dr. Philip Landrigan about his latest research into air pollution and how African countries are in a prime position to take action against it.

12 Nov 2021

Researchers receive a five-year grant renewal to discover and validate VCID biomarkers

Researchers at the University of Kentucky's Sanders-Brown Center on Aging recently received a five-year grant renewal of their MarkVCID program from the National Institutes of Health (NIH). The award total is more than $6 million.

11 Nov 2021

New therapy harnesses "dancing molecules" to reverse paralysis, repair tissue after spinal cord injuries

Northwestern University investigators have developed a new injectable therapy that harnesses "dancing molecules" to reverse paralysis and repair tissue after severe spinal cord injuries.

11 Nov 2021

New biomarkers could help determine synaptic damage and neurodegeneration in Alzheimer's

Alzheimer's disease is the main neurodegenerative disease in old people for which there is no treatment or efficient prevention yet.

10 Nov 2021

Cancer drugs could be repurposed as potential therapies for Alzheimer's disease

Existing and emerging cancer drugs could be repurposed as therapies to be tested in clinical trials for people at genetic risk of Alzheimer's disease, according to a new study published in Science Advances.

10 Nov 2021

Repeated listening to favorite music induces beneficial brain plasticity in Alzheimer’s patients

Researchers at the University of Toronto and Unity Health Toronto have demonstrated that repeated listening to personally meaningful music induces beneficial brain plasticity in patients with mild cognitive impairment or early Alzheimer's disease.

9 Nov 2021

Research opens the door to new therapeutic options for Parkinson's disease

These advances have been reported in a new scientific article published in the international journal Nature, fruit of the collaboration between Northwestern University (Chicago), Weill Cornell Medical College (New York) and the Institute of Biomedicine of Seville HUVR/CSIC/US/ and Ciberned.

8 Nov 2021

International Alzheimer’s trial to evaluate a combination of drugs targeting two brain proteins

Trial participant Rachel Habiger meets in 2018 with Randall J. Bateman, MD, the director of the Dominantly Inherited Alzheimer Network Trials Unit at Washington University School of Medicine in St. Louis.

8 Nov 2021

Alzheimer’s Disease – A Global Response to a Global Challenge

Alzheimer’s Disease remains both a current issue and a future challenge. Levels of the disease in the European Union have been predicted to double from the current estimate of 7,853,705 to 14,298,671 by 2050

From Biophys Ltd. 8 Nov 2021

Deletion of ABI3 gene in the brain may increase risk of developing Alzheimer’s disease

When immune cells move throughout the brain, they act as the first line of defense against viruses, toxic materials and damaged neurons, rushing over to clear out them.

7 Nov 2021

Prescription drug for multiple sclerosis improves memory in Alzheimer's mouse model

Losing memory is a hallmark of Alzheimer's, a symptom of the disease that depletes a patient's quality of life. Improving memory and slowing cognitive changes caused by the disease is an ongoing challenge for researchers seeking to develop novel therapies.

7 Nov 2021

Alzheimer's Disease News and Research

Further Reading

Physical activity may reduce immune cell activation to improve brain health in Alzheimer's disease

KHN’s ‘What the Health?’: Boosting confusion

Smartphone memory apps can help older adults with mild dementia to complete daily tasks

Novel long-read sequencing reveals complete repertoire of brain-expressed gene isoforms

New AI application reads eye movements

Study offers new insight into the role of tau proteins in ALS pathogenesis

Scientists develop a promising new approach to potentially treat Alzheimer's disease

Common hypertension drug not effective in slowing down the progression of Alzheimer's disease

£375 million Government funding to improve treatment for neurodegenerative diseases

Will the future of global health rely upon addressing air pollution?

Researchers receive a five-year grant renewal to discover and validate VCID biomarkers

New therapy harnesses "dancing molecules" to reverse paralysis, repair tissue after spinal cord injuries

New biomarkers could help determine synaptic damage and neurodegeneration in Alzheimer's

Cancer drugs could be repurposed as potential therapies for Alzheimer's disease

Repeated listening to favorite music induces beneficial brain plasticity in Alzheimer’s patients

Research opens the door to new therapeutic options for Parkinson's disease

International Alzheimer’s trial to evaluate a combination of drugs targeting two brain proteins

Alzheimer’s Disease – A Global Response to a Global Challenge

Deletion of ABI3 gene in the brain may increase risk of developing Alzheimer’s disease

Prescription drug for multiple sclerosis improves memory in Alzheimer's mouse model

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News